Alliancebernstein L.P. Vaxcyte, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 141,486 shares of PCVX stock, worth $4.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141,486

Previous 1,704,211 91.7%

Holding current value

$4.59 Million

Previous $64.4 Million 92.85%

% of portfolio

0.0%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$28.04 - $37.2 $43.8 Million - $58.1 Million	-1,562,725 Reduced 91.7%	141,486 $4.6 Million
Q1 2025 May 15, 2025	SELL	$37.76 - $92.13 $2.84 Million - $6.92 Million	-75,151 Reduced 4.22%	1,704,211 $64.4 Million
Q4 2024 Feb 12, 2025	BUY	$80.97 - $117.93 $10.8 Million - $15.7 Million	133,448 Added 8.11%	1,779,362 $146 Million
Q3 2024 Nov 14, 2024	SELL	$70.52 - $117.12 $6.27 Million - $10.4 Million	-88,907 Reduced 5.12%	1,645,914 $188 Million
Q2 2024 Aug 14, 2024	SELL	$60.06 - $78.77 $2.76 Million - $3.61 Million	-45,882 Reduced 2.58%	1,734,821 $131 Million
Q1 2024 May 14, 2024	SELL	$59.79 - $81.05 $8.03 Million - $10.9 Million	-134,344 Reduced 7.02%	1,780,703 $122 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $1.31 Million - $1.83 Million	-28,783 Reduced 1.48%	1,915,047 $120 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $2.56 Million - $2.96 Million	55,724 Added 2.95%	1,943,830 $99.1 Million
Q2 2023 Aug 15, 2023	BUY	$34.66 - $54.07 $62.6 Million - $97.6 Million	1,804,718 Added 2164.24%	1,888,106 $94.3 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $351,819 - $457,840	9,700 Added 13.16%	83,388 $3.13 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $586,283 - $1.37 Million	28,488 Added 63.03%	73,688 $3.53 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $21,216 - $31,895	1,200 Added 2.73%	45,200 $984,000
Q1 2022 May 13, 2022	BUY	$17.46 - $26.36 $120,474 - $181,884	6,900 Added 18.6%	44,000 $1.06 Million
Q3 2021 Nov 10, 2021	BUY	$20.26 - $26.97 $139,794 - $186,093	6,900 Added 22.85%	37,100 $941,000
Q2 2021 Jul 30, 2021	BUY	$16.45 - $24.06 $128,310 - $187,668	7,800 Added 34.82%	30,200 $680,000
Q1 2021 May 06, 2021	SELL	$18.66 - $29.16 $74,640 - $116,640	-4,000 Reduced 15.15%	22,400 $442,000
Q3 2020 Nov 12, 2020	BUY	$26.5 - $55.4 $699,600 - $1.46 Million	26,400 New	26,400 $1.3 Million

Others Institutions Holding PCVX

# of Institutions

324

Shares Held

139M

Call Options Held

229K

Put Options Held

160K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $1.92B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Vaxcyte, Inc. Transaction History